Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page now states that no participants are being recruited, and adds new user guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with the updated Intervention/Treatment heading and a revision note indicating the current version.SummaryDifference0.4%

- Check13 days agoChange DetectedA new page revision label, v3.5.5, was added and the previous label, v3.5.4, was removed. This update updates the page metadata to reflect the current revision of the record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision label v3.5.4 and removed the previous v3.5.3. This updates the page's version reference to reflect the latest revision.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release/build change without altering the study details shown.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This update seems to be a site versioning change rather than a modification to study content.SummaryDifference0.1%

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.